EHA Research & Mobilty Grants

EHA Library, Sabine Eichinger, 277630

IL7R EXPRESSION PREDICTS T-ALL SENSITIVITY TO JAK INHIBITORS REGARDLESS OF IL7R/JAK/STAT MUTATIONAL STATUS

EHA Library, Ludovic Lhermitte, 267214

IMPACT OF PRE-TRANSPLANT DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN CORD BLOOD TRANSPLANTATION ON BEHALF OF THE TRANSPLANT COMPLICATIONS WORKING GROUP OF JSHCT

EHA Library, Shigeo Fuji, 267319

CHRONIC MYELOID LEUKEMIA IS ASSOCIATED WITH INCREASED NEUTROPHIL EXTRACELLULAR TRAP FORMATION THAT IS AUGMENTED BY PONATINIB - A POTENTIAL CONTRIBUTOR TO VASCULAR TOXICITY?

EHA Library, Ofir Wolach, 267328

JUNCTIONAL ADHESION MOLECULE A (JAM-A) IS A CRITICAL REGULATOR OF HSC HOMING AND MAINTENANCE OF STEM CELL QUIESCENCE

EHA Library, Ben Cao, 267340

THE BRAF INHIBITOR VEMURAFENIB COMBINED WITH RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE REMISSIONS IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE-2 TRIAL

EHA Library, Enrico Tiacci, 267305

A MULTICENTRE, RANDOMIZED, NON-INFERIORITY TRIAL COMPARING THE EFFICACY OF DEFERIPRONE VERSUS DEFERASIROX IN PEDIATRIC PATIENTS AFFECTED BY TRANSFUSION-DEPENDENT HEMOGLOBINOPATHIES (DEEP-2 TRIAL)

EHA Library, Antonis KATTAMIS, 267345

THE FIRST-IN-CLASS, ORALLY AVAILABLE BMI-1 MODULATORS PTC-028 AND PTC596 DISPLAY POTENT ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMA

EHA Library, Arnold Bolomsky, 267323

NGS-BASED COPY-NUMBER ANALYSIS IN MORE THAN 2,000 PATIENTS WITH MYELOID NEOPLASMS

EHA Library, Ryunosuke Saiki, 267336

GENETICS AND MODELING OF HUMAN ACUTE ERYTHROID LEUKEMIA

EHA Library, Alexandre Fagnan, 267314

TRANSCEND CLL 004: MINIMAL RESIDUAL DISEASE NEGATIVE RESPONSES AFTER LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, Tanya Siddiqi, 267310

LUSPATERCEPT INCREASES FETAL HEMOGLOBIN (HBF) LEVELS IN ADULT Β-THALASSEMIA PATIENTS WHO REQUIRE RED BLOOD CELL (RBC) TRANSFUSIONS

EHA Library, Maria-Domenica Cappellini, 267344

MLL FUSIONS AFFECT SPLICING TO INDUCE EXPLOITABLE METABOLIC DEPENDENCIES

EHA Library, Robert Slany, 267313

SAFETY ANALYSIS OF VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): SECOND INTERIM ANALYSIS FROM THE PHASE II VISION HO141 TRIAL

EHA Library, Arnon Kater, 267309

THE ROLE OF ANTI-THYMOCYTE GLOBULIN WITH THIOTEPA-BUSULFAN-FLUDARABINE BASED CONDITIONING IN PATIENTS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANT AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

EHA Library, Jean El Cheikh, 267318

SINGLE-CELL CHARACTERIZATION OF THE MULTIPLE MYELOMA (MM) IMMUNE MICROENVIRONMENT IDENTIFIES CD27- T CELLS AS POTENTIAL SOURCE OF TUMOR-REACTIVE LYMPHOCYTES

EHA Library, CIRINO BOTTA, 267322

OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS, LYMA-101 TRIAL - A LYSA TRIAL

EHA Library, Steven Le, 267304

COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS.

EHA Library, Chinmay Munje, 267327

A DISTINCT WAVE OF HSC-DERIVED T CELL-ILC-RESTRICTED PROGENITORS INITIATES THE EMBRYONIC THYMUS

EHA Library, Ramy ELSAID, 267339

TRANSIENT SUBCLONES CARRYING NT5C2 MUTATIONS DEFINE A HIGH-RISK PATIENT GROUP WITH POOR OUTCOME IN PEDIATRIC RELAPSED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Malwine Pogodzinski, 267331

CLONAL HEMATOPOIESIS IN ELDERLY TWINS : CONCORDANCE, DISCORDANCE AND SURVIVAL

EHA Library, Jakob Werner Hansen, 267335

FIRST-IN-CLASS ORAL FERROPORTIN INHIBITOR: MODE OF ACTION AND EFFICACY IN A MOUSE MODEL OF BETA-THALASSEMIA INTERMEDIA

EHA Library, Vania Manolova, 267343

A BUSULFAN FOLLOWING CYCLOPHOSPHAMIDE, PROTOCOL IMPROVED RESULTS IN ALTERNATIVE DONOR TRANSPLANT FOR PATIENTS WITH THALASSEMIA MAJOR: A RESULT FROM LONG-TERM LARGE-SIZE MULTI-CENTER STUDY IN CHINA

EHA Library, Chunfu Li, 267317

FIVE-YEAR FOLLOW-UP OF PATIENTS RECEIVING IBRUTINIB FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alessandra Tedeschi, 267308

PATHWAY AND GENE SET OVERDISPERSION ANALYSIS OF SINGLE CELL TRANSCRIPTOMIC DATA FROM PATIENTS WITH CHRONIC MYELOID LEUKAEMIA HIGHLIGHTS TRANSCRIPTIONAL HETEROGENEITY IN CD34+CD38- CELLS

EHA Library, William Dunn, 267326

POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIAL

EHA Library, pau abrisqueta, 267303

SIRT5 IS REQUIRED FOR ACUTE MYELOID LEUKEMIA GROWTH AND SURVIVAL AND MAY REPRESENT A NOVEL THERAPEUTIC TARGET

EHA Library, Michael W Deininger, 267312

IMPACT OF MESURABLE RESIDUAL DISEASE POSITIVITY ON OUTCOMES FOLLOWING UNMBILICAL CORD BLOOD TRANSPLANTATION : A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT AND EUROCORD

EHA Library, Frederic Baron, 267316

CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION-DEPENDENT Β-THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB-204) STUDY

EHA Library, Mark C. Walters, 267342

CHRONOLOGY OF COPY NUMBER ALTERATIONS FROM PRECURSORS TO MULTIPLE MYELOMA: WHAT COMES FIRST?

EHA Library, Mehmet Samur, 267321

HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL

EHA Library, Othman Al-Sawaf, 267307

IDENTIFICATION OF THE DOPAMINE AND SEROTONIN TRANSPORTERS SLC6A3 AND SLC6A4 AS NOVEL SURVIVAL FACTORS IN LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Abdulkarim Aldosari, 267325

TP53 SOMATIC MUTATIONS AS PRE-LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Guranda Chitadze, 267330

DNA METHYLATION DYNAMICS IDENTIFY LINEAGE-SPECIFIC REGULATION PATTERNS OF HEMATOPOIETIC DIFFERENTIATION

EHA Library, Sina Stäble, 267338

EX VIVO DRUG SENSITIVITY PROFILING IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS DEFINES NOVEL DRUG SENSITIVITY PATTERNS FOR PREDICTING CLINICAL THERAPEUTIC OUTCOMES

EHA Library, Alexey Aleshin, 267334

EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: RESULTS OF THE PHASE III MABCUTE STUDY

EHA Library, Simon Rule, 267302

REPROGRAMMING HEMATOPOIETIC STEM CELL FUNCTION VIA MODULATION OF MITOCHONDRIAL ACTIVITY

EHA Library, Mukul Girotra, 267337

BIOLOGICAL CHARACTERIZATION OF THE U2AF1 S34F MUTATION IN THE PATHOGENESIS OF MYELODYSPLASIA

EHA Library, Ayana Kon, 267333

BCP- AND T-ALL CELLS HIDE IN DISTINCT NICHES OF THE BONE MARROW

EHA Library, Danaëlle Capron, 267329

SETD2 LOSS OF FUNCTION IS A RECURRENT EVENT IN ADVANCED-PHASE CHRONIC MYELOID LEUKEMIA INDUCED BY POST-TRANSLATIONAL MECHANISMS THAT CAN BE THERAPEUTICALLY TARGETED

EHA Library, Manuela Mancini, 267324

RESULTS FROM THE PHASE 3 NORTHSTAR-3 STUDY EVALUATING LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSAEMIA AND A Β0 OR IVS-I-110 MUTATION AT BOTH ALLELES OF THE HBB GENE

EHA Library, Andreas E. Kulozik, 267341

THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MM

EHA Library, Mehmet Samur, 267320

POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMT

EHA Library, Arnon Nagler, 267315

SCREENING OF CLUSTERED REGULATORY ELEMENTS REVEALS NOVEL LEUKEMIA DEPENDENCIES

EHA Library, Camille Lobry, 267311

GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORAMBUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY

EHA Library, Stephan Stilgenbauer, 267306

TREATMENT-DEPENDENCE OF HIGH-RISK GENE EXPRESSION SIGNATURES IN DE NOVO FOLLICULAR LYMPHOMA

EHA Library, Christopher Bolen, 267301

Is iron chelation really necessary in MDS?

EHA Library, Eva Hellström- Lindberg, 274190

Epigenomic changes mediating leading risk scenarios for initiation and progression of cancers. Implications for prevention, interception and therapy

EHA Library, Stephen Baylin, 274189

DECIPHERING THE ROLE OF RUNX1 ISOFORMS IN THE DEVELOPMENT OF TRANSIENT ABNORMAL MYELOPOIESIS

EHA Library, Sofia Gialesaki, 274188

RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE

EHA Library, Jo Howard, 274185

TFR2-HAPLOINSUFFICIENCY ENHANCES THE BENEFICIAL EFFECT OF TMPRSS6-ANTISENSE OLIGONUCLEOTIDE TREATMENT IN BETA-THALASSEMIA MICE

EHA Library, Antonella Nai, 274184

Management of posttransplant lymphoproliferative disorders

EHA Library, Daan Dierickx, 273681

The pathology of Epstein-Barr virus lymphoproliferations

EHA Library, Stefan Dojcinov, 273680

EBV infection - an hematological perspective

EHA Library, Olivier Hermine, 273679

The impact of spliceosome mutations in MDS

EHA Library, Jacqueline Boultwood, 273697

Splenectomy and emerging novel treatments in rare inherited hemolytic anemias

EHA Library, Hannah Tamary, 273705

Hereditary spherocytosis and allied disorders

EHA Library, Roberta Russo, 273704

Red cell membrane proteins

EHA Library, Lesley Bruce, 273703

The role of innate immunity in MDS pathogenesis

EHA Library, Alan List, 273698

High risk MDS after HMAs

EHA Library, Lionel ADES, 273699

Fibrosis driving myelofibroblast precursors in MPN & new therapeutic pathways

EHA Library, Rebekka Schneider, 273700

Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms

EHA Library, Jyoti Nangalia, 273701

MF management

EHA Library, Srdan Verstovsek, 273702

Relevant subtypes in childhood ALL

EHA Library, Hélène Cavé, 273709

Molecular driven DLBCL therapy: Ready for the prime time?

EHA Library, Marek Trneny, 273693

Molecular classification of aggressive B-cell lymphoma

EHA Library, Bjoern Chapuy, 273692

NGS in CML - New standard diagnostic procedure?

EHA Library, Susan Branford, 273673

TKI safety

EHA Library, Henrike Hjorth-Hansen, 273674

Current treatment approaches in CML

EHA Library, Gianantonio Rosti, 273675

Genomic landscape of Waldenström’s macroglobulinemia

EHA Library, Steven Treon, 273676

Waldenström’s macroglobulinemia front line treatment

EHA Library, Alessandra Tedeschi, 273677

Treatment options for relapsed Waldenström's Macroglobulinemia

EHA Library, Christian Buske, 273678

Opportunities and challenges of personalized therapy of patients with HR ALL

EHA Library, Shai Izraeli, 273710

Current Perspectives in T-ALL

EHA Library, Adolfo Ferrando, 273711

Platelet-neutrophil crosstalk and netosis

EHA Library, Konstantin Stark, 273685

Disseminated intravascular coagulation - What can we do?

EHA Library, Cheng-Hock Toh, 273686

Management of coagulation disorders in severe inflammation

EHA Library, Riitta Lassila, 273687

Aggressive B-cell lymphoma subtyping: a Pathologist's viewpoint

EHA Library, Daphne de Jong, 273691

Targeting leukemia with HLA class II restricted T cells

EHA Library, Fred Falkenburg, 274215

THE ANALYSIS OF GENE MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA

EHA Library, Natallia Klimkovich, 267534

CHILDHOOD ACUTE MYELOID LEUKEMIA IN SOUTHERN TUNISIA: ABOUT 52 CASES

EHA Library, olfa kassar, 267533

REAL WORLD COMPARISON OF THE TWO HYPOMETHYLATING AGENTS IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS- SINGLE INSTITUTION EXPERIENCE FROM INDIA

EHA Library, CHETHAN R, 267532

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IMPROVES SURVIVAL IN AML PATIENTS WITH HIGH FLT3-ITD ALLELIC RATIO

EHA Library, Apostolia Papalexandri, 267531

ASSESSMENT OF FLT3 MUTATION IN ACUTE MYELOID LEUKEMIA: RESULTS OF A SPANISH DELPHI PANEL SURVEY

EHA Library, Jorge Sierra, 267530

CLINICAL FEATURES AND TREATMENT OUTCOME OF ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA

EHA Library, olfa kassar, 267529

THE ROLE OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA: THE EFFECT ON THE COURSE OF THE DISEASE AND THE RESULTS OF THERAPY

EHA Library, Asiyat Radzhabova, 267528

A SIMPLE FLOW CYTOMETRY-BASED SCORE MAY OPTIMIZE TESTING FOR BIALLELIC CEBPA MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Fabio Guolo, 267526

EVOLUTION OF EFFICACY IN APL TREATMENT WITHIN RUSSIAN MULTICENTER TRIALS 1992-2019.

EHA Library, Olga Aleshina (Gavrilina), 267525

STUDY ON MECHANISM OF MATERIA MEDICA HEDYOTIS DIFFUSA REGULATING MITOCHONDRIAL MORPHOLOGY AND FUNCTION TO INDUCE APOPTOSIS IN KG1A CELLS

EHA Library, Ruirong Xu, 267523

PROGNOSTIC IMPACT OF ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Ines Turki, 267522

THERAPEUTIC POTENCIAL OF GAMBOGIC ACID AND SILIBININ IN ACUTE MYELOBLASTIC LEUKEMIA – IN VITRO STUDIES

EHA Library, Raquel Alves, 267521

PPP1R15A GENE IS OVEREXPRESSED IN CHEMORESISTANT ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Frieda KONTSIOTI, 267520

ANALYSIS OF MICRO-RNAS EXPRESSION PROFILE IN EXOSOMES DERIVED FROM ACUTE MYELOID LEUKEMIA BY KNOCKDOWN P62 AND THE EFFECT ON ANGIOGENESIS

EHA Library, Hu R, 267519

SUCCESSFUL HAPLOIDENTIC BONE MARROW TRANSPLANTATION WITH INOTUZUMAB OZOGAMICIN IN PATIENT WITH RELAPSED AND RESISTANT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ali Ünal, 267518

OUTCOME OF PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ALL IN SOUTHERN TUNISIA: ABOUT 13 CASES

EHA Library, Imen Frikha, 267516

BONE MARROW NECROSIS IN A PATIENT FOLLOWING BLINATUMOMAB THERAPY

EHA Library, Nese Yarali, 267515

FEASIBILITY AND OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANTATION IN ADULT PHI NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Imen Frikha, 267514

ABERRANT EZH2 HIGH EXPRESSION IN THE PATIENTS WITH ACUTE LEUKEMIA AND EFFECT OF A NOVEL EZH2 INHIBITOR GSK126 ON CELL PROLIFERATION AND APOPTOSIS OF THE MALIGNANT CELLS

EHA Library, Chunhua song, 267513

EXOSOMES-MEDIATED DELIVERY OF RNA OLIGOS DIRECTED TO CHE-1/AATF IMPAIRS BCP-ALL VITALITY

EHA Library, Matteo Caforio, 267512

ADULT ACUTE LEUKEMIA AND SEASONALITY: A SINGLE CENTER EXPERIENCE

EHA Library, Derya Sahin, 267517